AI Summary: Ursodiol is the first-line medication for primary biliary cholangitis, and Ocaliva is a second-line option for adults who do not respond to it or cannot take it.
Cholestatic Liver Disease Therapy
Medically reviewed.
Cholestatic liver disease therapy is a group of prescription medications used when bile flow through the liver and bile ducts is impaired (cholestasis). The most common target is primary biliary cholangitis (PBC), also called primary biliary cirrhosis. These medicines help improve bile flow, reduce bile acid–related liver injury, and slow disease progression.
This page explains how ursodeoxycholic acid (ursodiol) and obeticholic acid (Ocaliva) are used, who may benefit, how your response is checked, and how everyday habits support treatment. You can also connect with a liver specialist to discuss whether one of these therapies fits your care plan.
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
What is Cholestatic Liver Disease Therapy and Who May Benefit
Cholestatic liver disease therapy is a class of liver-directed treatments used when bile cannot flow normally through the liver and bile ducts. When bile acids build up, they can injure liver cells over time. Treatment aims to improve bile flow, protect liver cells, ease inflammation, and slow disease progression. Care typically combines medication, regular monitoring, and healthy lifestyle habits.
The two therapies on this page are used mainly for primary biliary cholangitis (PBC), an autoimmune disease that damages the bile ducts. There is no cure for PBC, but medications can slow the disease and may help prevent complications. Because the right approach depends on your diagnosis, overall health, and response to treatment, connecting with a liver specialist can help you understand which option fits your care plan.
Ursodiol is a naturally occurring bile acid and the first-line medication for PBC. It improves bile flow, reduces the harmful effects of bile acid buildup, and helps protect liver cells from bile-related injury. It is generally a long-term treatment.
Ocaliva is a once-daily tablet for adults with PBC who do not respond well enough to ursodiol or cannot take it. It activates farnesoid X receptors (FXR) in the liver to help regulate how bile acids are made and moved, which improves bile flow and liver enzyme levels.
Providers typically consider these therapies for adults with PBC, or when impaired bile flow is causing liver injury. Ursodiol is the usual starting point. Ocaliva is added or substituted when ursodiol does not work well enough or is not tolerated. Only a qualified healthcare provider can decide which option is right for you.
DIET & LIFESTYLE SUPPORT
How Lifestyle Changes Support Cholestatic Liver Disease Therapy
Cholestatic liver disease therapy works best when combined with healthy daily habits. Nutrition, avoiding alcohol unless your provider says otherwise, weight management, and consistent follow-up all support what these medications can do for your liver.
Balanced diet and alcohol
A healthy, balanced diet supports overall liver health during treatment. Avoid alcohol unless your healthcare provider tells you otherwise.
Fat-soluble vitamins
When bile flow is poor, the body may absorb fat-soluble vitamins (A, D, E, and K) less well. If a deficiency develops, your provider may recommend supplements.
Healthy weight, activity, and routine
Staying at a healthy weight, staying physically active, taking your medication consistently, and keeping follow-up appointments all help your treatment work as intended.
Connect with a liver specialist to discuss whether cholestatic liver disease therapy fits your care plan.
HOW TREATMENT IS SEQUENCED
How Cholestatic Liver Disease Therapy Is Sequenced in PBC
Treatment for primary biliary cholangitis follows a step-by-step approach. Ursodiol comes first. Your provider then checks how well it is working and decides whether another medication should be added.
The steps below describe the usual path. Your own plan depends on your test results, your overall health, and how advanced your liver disease is.
Step 1: Ursodiol as first-line treatment
Ursodiol is recommended for people with PBC who have abnormal liver enzyme levels, whatever the stage of liver scarring. It improves liver blood tests and slows the progression of liver damage.
Step 2: Checking your response
Providers check how well ursodiol is working about 12 months after you start. A good response is a strong sign of better long-term outcomes. If your liver tests stay abnormal, your provider may consider a second-line option.
Step 3: Second-line options
Ocaliva is a second-line option for adults who do not respond well enough to ursodiol or cannot tolerate it. Some providers may also consider other medications. Ocaliva and fibrates are discouraged in people with decompensated liver disease (Child-Pugh B or C).
Managing symptoms alongside therapy
Itching (pruritus) can be a hard symptom of PBC. Medicines that bind bile acids in the gut are the usual first choice for itching. Because PBC can weaken bones, your provider may also recommend calcium and vitamin D.
Monitoring Liver Health During Cholestatic Liver Disease Therapy
Regular monitoring helps your healthcare provider see how your liver is responding to treatment and spot changes over time. Follow-up care usually centers on blood tests, with imaging added when needed.
Blood tests
Liver function tests track enzymes and other markers of liver injury. They show whether bile flow and liver health are improving on treatment.
Your provider compares your liver tests before and after treatment, including the check about 12 months after starting ursodiol, to decide whether your plan should change.
Imaging of the liver and bile ducts helps rule out blockages. Transient elastography can track liver stiffness, and rising stiffness over time is linked to worse outcomes.
Answers to Common Cholestatic Liver Disease Therapy Questions
What is cholestatic liver disease therapy used for?
Cholestatic liver disease therapy is a group of medications used when bile flow through the liver is impaired, most often in primary biliary cholangitis (PBC). The two therapies covered here are ursodiol (Actigall, Urso, Ursofalk) and obeticholic acid (Ocaliva). They help improve bile flow, reduce bile-related liver injury, and slow disease progression. Talk with your liver specialist about whether this therapy fits your treatment plan.
How does ursodiol work?
Ursodiol is the first-line treatment for PBC. It is a naturally occurring bile acid that improves bile flow, reduces the toxic effects of bile acid buildup, and protects liver cells from bile-related injury. It is generally a long-term treatment, and continued use helps preserve liver function.
When is Ocaliva used instead of, or along with, ursodiol?
Ocaliva is for adults with PBC who do not respond well enough to ursodiol or cannot tolerate it. It activates farnesoid X receptors (FXR) in the liver to help regulate bile acid production and transport, which improves bile flow and liver enzyme levels. Your provider decides whether it suits you based on your health and liver condition.
How will I know if my treatment is working?
Providers check how well ursodiol is working about 12 months after you start it. They look at your liver blood tests. If the tests remain abnormal, your provider may consider a second-line option such as Ocaliva.
What are the common side effects?
The most common side effects of ursodiol are diarrhea, abdominal discomfort, nausea, headache, and weight gain. The most common side effects of Ocaliva are itching, fatigue, abdominal discomfort, joint pain, and dizziness. Your healthcare provider will monitor you regularly and can help manage any side effects that arise.
Can I stop lifestyle changes after starting treatment?
Yes, you should keep up healthy habits, because medication works alongside them rather than replacing them. Eat a balanced diet, avoid alcohol unless your provider says otherwise, stay at a healthy weight, stay active, take your medication consistently, and attend follow-up visits. Ask your provider whether you need fat-soluble vitamin supplements.
Is there treatment for itching caused by cholestasis?
Yes, itching (pruritus) can be a hard symptom of PBC, and it has its own treatment. Medicines that bind bile acids in the gut are the usual first choice. Tell your healthcare provider if itching affects your daily life so they can recommend the right option.
LIVER HEALTH UPDATES
Stay updated on liver health insights
Get the latest updates on liver tests, screening recommendations, result interpretation, and liver health insights delivered straight to your inbox.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.